Kits
Serum Crosslaps® (CTX-I) ELISA
Kits
Description
The Serum CrossLaps® (CTX-I) ELISA is an enzyme immunological test for the quantification of degradation products of C-terminal telopeptides of Type I collagen in human serum and plasma.
The Serum CrossLaps® (CTX-I) ELISA assay is intended for in-vitro diagnostic use as an indication of human bone resorption and may be used as an aid in:
1. Monitoring bone resorption changes of:
a) Anti-resorptive therapies in postmenopausal women1, 2:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
b) Anti-resorptive therapies in individuals diagnosed with osteopaenia:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
2. Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing
anti-resorptive therapies:
a) Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
b) Bisphosphonate therapies
The Serum CrossLaps® (CTX-I) ELISA assay is intended for in-vitro diagnostic use as an indication of human bone resorption and may be used as an aid in:
1. Monitoring bone resorption changes of:
a) Anti-resorptive therapies in postmenopausal women1, 2:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
b) Anti-resorptive therapies in individuals diagnosed with osteopaenia:
Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
Bisphosphonate therapies
2. Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing
anti-resorptive therapies:
a) Hormone Replacement Therapies (HRT) with hormones and hormone-like drugs
b) Bisphosphonate therapies